ExLibris header image
SFX Logo
Title: Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Toth, K yr:2008


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Parker, S. "Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001." Antiviral therapy 13.7 (2008): 863-73. Link to SFX for this item
2. Burton, Dennis R R. "Toward an AIDS vaccine." Science 320.5877 (2008): 760-4. Link to SFX for this item
3. Johnston, Margaret I I. "An HIV vaccine--evolving concepts." The New England journal of medicine 356.20 (2007): 2073-81. Link to SFX for this item
4. Bernstein, A. "AIDS and the next 25 years." Science 320.5877 (2008): 717-717. Link to SFX for this item
5. Johnston, Margaret I. "Current concepts: An HIV vaccine - Evolving concepts." The New England journal of medicine 356.20 (2007): 2073-2081. Link to SFX for this item
6. Balzarini, J. "The regulation of HIV-1 transcription: Molecular targets for chemotherapeutic intervention." Medicinal research reviews 26.5 (2006): 595-625. Link to Full Text for this item Link to SFX for this item
7. Sekaly, RP P. "The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?" The Journal of experimental medicine 205.1 (2008): 7-12. Link to Full Text for this item Link to SFX for this item
8. "Rapid communication: Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model." Virology (2004): 474-. Link to SFX for this item
9. Parker, S. "Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model." Antiviral research 77.1 (2008): 39-49. Link to SFX for this item
10. Gray, E. "4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response." Journal of virology 82.5 (2008): 2367-2375. Link to Full Text for this item Link to SFX for this item
11. Davenport, M. "Understanding the mechanisms and limitations of immune control of HIV." Immunological reviews 216.1 (2007): 164-175. Link to Full Text for this item Link to SFX for this item
12. Barouch, Dan H H. "Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes." Nature 415.6869 (2001): 335-9. Link to Full Text for this item Link to SFX for this item
13. Dwek, Raymond A. "Exploiting the defensive sugars of HIV-1 for drug and vaccine design." Nature 446.7139 (2007): 1038-1045. Link to Full Text for this item Link to SFX for this item
14. Haynes, Barton F. "The quest for an antibody-based HIV vaccine." Immunological reviews 275.1 (2017): 5-10. Link to Full Text for this item Link to SFX for this item
15. Tarantola, D. "Ethical considerations related to the provision of care and treatment in vaccine trials." Vaccine 25.26 (2007): 4863-74. Link to SFX for this item
16. Pantaleo, G. "An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses." The Journal of experimental medicine 205.1 (2007): 63-77. Link to Full Text for this item Link to SFX for this item
17. "The Toughest Nut to Crack: Will We Ever Have a Preventive and Effective HIV-1 Vaccine?" Molecular therapy. 92.11: 1896-1897. Link to SFX for this item
18. Kager, P A A. "[The treatment of falciparum malaria]." Nederlands tijdschrift voor geneeskunde 151.40 (2007): 2192-4. Link to SFX for this item
19. Bieniasz, Paul D D. "Intrinsic immunity: a front-line defense against viral attack." Nature immunology 5.11 (2004): 1109-15. Link to Full Text for this item Link to SFX for this item
20. Dubey, S. "Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay." Journal of acquired immune deficiency syndromes 45.1 (2007): 20-27. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.